Free Trial

DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY24 Earnings Guidance

DENTSPLY SIRONA logo with Medical background

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of $1.82-$1.86 for the period, compared to the consensus EPS estimate of $1.98. DENTSPLY SIRONA also updated its FY 2024 guidance to 1.820-1.860 EPS.

DENTSPLY SIRONA Stock Down 28.0 %

XRAY traded down $6.72 on Thursday, hitting $17.26. The company had a trading volume of 29,886,019 shares, compared to its average volume of 3,084,600. The stock has a fifty day simple moving average of $24.99 and a 200-day simple moving average of $26.04. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The firm has a market capitalization of $3.50 billion, a P/E ratio of -22.27, a P/E/G ratio of 1.27 and a beta of 1.02. DENTSPLY SIRONA has a 52-week low of $17.22 and a 52-week high of $37.60.

Analysts Set New Price Targets

A number of research firms have issued reports on XRAY. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Wednesday. Barrington Research reiterated an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating on the stock in a research note on Monday, July 22nd. Evercore ISI decreased their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Finally, Stifel Nicolaus lowered their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Moderate Buy" and an average price target of $31.88.

Read Our Latest Report on XRAY

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines